FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

15937911000001100: Saxagliptin hydrochloride (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    56373701000001114 Saxagliptin hydrochloride (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    56373801000001117 Saxagliptin hydrochloride en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Saxagliptin hydrochloride Is a Substance with dipeptidyl peptidase IV inhibitor mechanism of action false Inferred relationship Existential restriction modifier
    Saxagliptin hydrochloride Is a Oral hypoglycemic false Inferred relationship Existential restriction modifier
    Saxagliptin hydrochloride Is a Saxagliptin false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Saxagliptin 5mg tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 5mg tablets 28 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 2.5mg tablets 28 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Waymade Healthcare Plc) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 2.5mg / Metformin 1g tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 2.5mg / Metformin 850mg tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 2.5mg / Metformin 850mg tablets 56 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 2.5mg tablets (Waymade Healthcare Plc) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Onglyza 2.5mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 5mg / Dapagliflozin 10mg tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier
    Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Saxagliptin hydrochloride Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start